Sa1284 MEPOLIZUMAB IMPROVES HISTOLOGIC SEVERITY AS MEASURED BY THE EOE-HSS IN ADOLESCENS AND ADULTS WITH EOSINOPHILIC ESOPHAGITIS IN A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL